Presentation TCT 2013

Cost-Effectiveness Considerations for Mild and Moderate Hypertension

Presenter: Mark Hlatky

October 27, 2013

REGISTER for free or LOG IN to view this content

Cost-Effectiveness Considerations for Mild and Moderate Hypertension

Renovascular

Presentation

TCT 2013

Up Next

Presentation TCT 2013

The Lifetech Iron-based BRS

Presenter: Deyuan Zhang

October 27, 2013

More slides +

Presentation TCT 2013

Device and Clinical Trial Update: EnligHTN (St. Jude)

Presenter: Stephen Worthley

October 27, 2013

Presentation TCT 2013

Beyond Resistant HTN: Heart Failure/Sleep Apnea and More

Presenter: Henry Krum

October 27, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.